Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain – a 28-week Extension Study
Condition(s):Chronic Nonmalignant PainLast Updated:September 10, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Chronic Nonmalignant PainLast Updated:September 10, 2012Completed
Condition(s):SuicideLast Updated:March 13, 2019Completed
Condition(s):Non-Hodgkin LymphomaLast Updated:March 27, 2024Recruiting
Condition(s):Diabetes Mellitus, Type 2Last Updated:February 2, 2015Completed
Condition(s):ThrombocytopaeniaLast Updated:April 18, 2016Completed
Condition(s):End Stage Renal Disease; AnemiaLast Updated:January 11, 2022Completed
Condition(s):Anemia, Iron-Deficiency; Inflammatory Bowel Disease; Crohn’s DiseaseLast Updated:November 2, 2020Completed
Condition(s):DermatomyositisLast Updated:February 8, 2024Completed
Condition(s):Aortic StenosisLast Updated:November 30, 2023Active, not recruiting
Condition(s):Metastatic Esophageal Adenocarcinoma; Metastatic Esophageal Squamous Cell Carcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Recurrent Esophageal Adenocarcinoma; Recurrent Esophageal Carcinoma; Recurrent Esophageal Squamous Cell Carcinoma; Recurrent Gastroesophageal Junction Adenocarcinoma; Stage IV Esophageal Cancer AJCC v7Last Updated:February 15, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.